zzbiotech-home

Developing Next-Generation Activated Protein C for Human Therapeutic Use

THE COMPANY

ZZ Biotech LLC is a clinical stage company developing innovative biologic treatments for ischemic stroke, other neurological diseases, and diabetic foot ulcers. ZZ Biotech was incepted in 2006 to focus on the development of 3K3A-APC.

STROKE PROGRAM

ZZ Biotech is running a Phase 2 clinical study in patients with moderate to severe ischemic stroke, supported by the National Institutes of Health.

FOOT ULCER PROGRAM

APC and 3K3A-APC have shown efficacy in several in vitro and in vivo wound healing studies. APC has also been studied in multiple human clinical wound healing studies, including a foot ulcer study.